compounded semaglutide crackdown news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Hims & Hers halts semaglutide

Common side effects include nausea, vomiting, diarrhea, constipation, headache, dizziness, fatigue, and abdominal pain

Could These Medications Help Lower Cancer Risk

When we constantly deny ourselves the foods we enjoy, we feel restricted and deprived

The primary outcome was all-cause death, with secondary outcomes including major adverse cardiovascular events (MACE), myocardial infarction, stroke, hospitalization, and coronary revascularization

The "Muscle Guard" strategy and supplement integration are designed to support performance and body composition during weight loss - brand-positioned elements that matter more to active people than to those who aren't training